tradingkey.logo
tradingkey.logo
Search

Regeneron Pharmaceuticals Inc Says Dupixent® (Dupilumab) To Treat Chronic Spontaneous Urticaria (Csu) Advances In EU With Positive CHMP Opinion

ReutersSep 22, 2025 4:31 AM
facebooktwitterlinkedin

- Regeneron Pharmaceuticals Inc REGN.O:

  • REGENERON PHARMACEUTICALS INC - DUPIXENT® (DUPILUMAB) TO TREAT CHRONIC SPONTANEOUS URTICARIA (CSU) ADVANCES IN EU WITH POSITIVE CHMP OPINION

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI